Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
{{output}}
Purpose of review: The IL-4/13 antagonist dupilumab was approved in 2017 as the first biologic for atopic dermatitis. Here, we comprehensively review compelling new data regarding dupilumab published following the approval. ... ...
